| Literature DB >> 24287381 |
Neil R Stokes1, Nicola Baker1, James M Bennett1, Pramod K Chauhan2, Ian Collins1, David T Davies1, Maruti Gavade2, Dushyant Kumar2, Paul Lancett1, Rebecca Macdonald1, Leanne Macleod1, Anu Mahajan2, Jeffrey P Mitchell3, Narendra Nayal2, Yashodanand Nandan Nayal2, Gary R W Pitt3, Mahipal Singh2, Anju Yadav2, Anil Srivastava2, Lloyd G Czaplewski1, David J Haydon4.
Abstract
The design, synthesis and structure-activity relationships of a series of oxazole-benzamide inhibitors of the essential bacterial cell division protein FtsZ are described. Compounds had potent anti-staphylococcal activity and inhibited the cytokinesis of the clinically-significant bacterial pathogen Staphylococcus aureus. Selected analogues possessing a 5-halo oxazole also inhibited a strain of S. aureus harbouring the glycine-to-alanine amino acid substitution at residue 196 of FtsZ which conferred resistance to previously reported inhibitors in the series. Substitutions to the pseudo-benzylic carbon of the scaffold improved the pharmacokinetic properties by increasing metabolic stability and provided a mechanism for creating pro-drugs. Combining multiple substitutions based on the findings reported in this study has provided small-molecule inhibitors of FtsZ with enhanced in vitro and in vivo antibacterial efficacy.Entities:
Keywords: 3-Methoxybenzamide; Antibacterial; Cell division; FtsZ; MRSA
Mesh:
Substances:
Year: 2013 PMID: 24287381 DOI: 10.1016/j.bmcl.2013.11.002
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823